Rau O - Search Results

1

The treatment of dyslipidemia--what's left in the pipeline?

Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M. Rau O, et al. ChemMedChem. 2008 Feb;3(2):206-21. doi: 10.1002/cmdc.200700165. ChemMedChem. 2008. PMID: 17963209 Review.

2

[New targets and drugs for treatment of lipid metabolism disorders].

Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M. Rau O, et al. Pharm Unserer Zeit. 2007;36(2):142-8. doi: 10.1002/pauz.200600213. Pharm Unserer Zeit. 2007. PMID: 17425000 Review. German. No abstract available.

3

Virtual screening for PPAR modulators using a probabilistic neural network.

Derksen S, Rau O, Schneider P, Schubert-Zsilavecz M, Schneider G. Derksen S, et al. Among authors: rau o. ChemMedChem. 2006 Dec;1(12):1346-50. doi: 10.1002/cmdc.200600166. ChemMedChem. 2006. PMID: 17066499 No abstract available.

4

Alpha-alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma.

Rau O, Syha Y, Zettl H, Kock M, Bock A, Schubert-Zsilavecz M. Rau O, et al. Arch Pharm (Weinheim). 2008 Mar;341(3):191-5. doi: 10.1002/ardp.200700209. Arch Pharm (Weinheim). 2008. PMID: 18275039

5

From molecular shape to potent bioactive agents I: bioisosteric replacement of molecular fragments.

Proschak E, Zettl H, Tanrikulu Y, Weisel M, Kriegl JM, Rau O, Schubert-Zsilavecz M, Schneider G. Proschak E, et al. Among authors: rau o. ChemMedChem. 2009 Jan;4(1):41-4. doi: 10.1002/cmdc.200800313. ChemMedChem. 2009. PMID: 19058279 No abstract available.

6

From molecular shape to potent bioactive agents II: fragment-based de novo design.

Proschak E, Sander K, Zettl H, Tanrikulu Y, Rau O, Schneider P, Schubert-Zsilavecz M, Stark H, Schneider G. Proschak E, et al. Among authors: rau o. ChemMedChem. 2009 Jan;4(1):45-8. doi: 10.1002/cmdc.200800314. ChemMedChem. 2009. PMID: 19058280 No abstract available.

7

From machine learning to natural product derivatives that selectively activate transcription factor PPARgamma.

Rupp M, Schroeter T, Steri R, Zettl H, Proschak E, Hansen K, Rau O, Schwarz O, Müller-Kuhrt L, Schubert-Zsilavecz M, Müller KR, Schneider G. Rupp M, et al. Among authors: rau o. ChemMedChem. 2010 Feb 1;5(2):191-4. doi: 10.1002/cmdc.200900469. ChemMedChem. 2010. PMID: 20043315 No abstract available.

8

Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor.

Rau O, Wurglics M, Dingermann T, Abdel-Tawab M, Schubert-Zsilavecz M. Rau O, et al. Pharmazie. 2006 Nov;61(11):952-6. Pharmazie. 2006. PMID: 17152989

9

Quinoline-based derivatives of pirinixic acid as dual PPAR alpha/gamma agonists.

Popescu L, Rau O, Böttcher J, Syha Y, Schubert-Zsilavecz M. Popescu L, et al. Among authors: rau o. Arch Pharm (Weinheim). 2007 Jul;340(7):367-71. doi: 10.1002/ardp.200700042. Arch Pharm (Weinheim). 2007. PMID: 17610302

10

Acidic elements in histamine H(3) receptor antagonists.

Sander K, von Coburg Y, Camelin JC, Ligneau X, Rau O, Schubert-Zsilavecz M, Schwartz JC, Stark H. Sander K, et al. Among authors: rau o. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1581-4. doi: 10.1016/j.bmcl.2010.01.089. Epub 2010 Jan 21. Bioorg Med Chem Lett. 2010. PMID: 20138762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters